The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation

Diane R Wonsey1, Karen I Zeller, Chi V Dang

  • 1Program in Human Genetics and Molecular Biology and Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Insights

This study identifies PRDX3 as a novel nuclear c-Myc target gene crucial for mitochondrial function. PRDX3 supports cancer cell proliferation and survival by maintaining mitochondrial integrity.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Mitochondrial Biology

Background:

  • Deregulated c-Myc is implicated in numerous human cancers.
  • c-Myc exerts its oncogenic effects primarily through transcriptional regulation of target genes.
  • The role of c-Myc in regulating mitochondrial function is not fully understood.

Purpose of the Study:

  • To identify and characterize novel c-Myc target genes involved in mitochondrial function.
  • To elucidate the role of PRDX3, a peroxiredoxin family member, as a c-Myc target gene.
  • To investigate the impact of PRDX3 on mitochondrial homeostasis and cancer cell phenotypes.

Main Methods:

  • Utilized the mycER system and c-myc(-/-) cells to study PRDX3 expression.
  • Performed chromatin immunoprecipitation (ChIP) to identify Myc binding sites on the PRDX3 gene.
  • Employed mitochondria-specific fluorescent probes to assess mitochondrial function.

Main Results:

  • PRDX3 expression is induced by Myc and reduced in c-myc deficient cells.
  • Myc binds to a specific region of the PRDX3 genomic locus.
  • PRDX3 is essential for Myc-mediated proliferation, transformation, and resistance to glucose withdrawal.
  • PRDX3 maintains mitochondrial mass and membrane potential in cancer cells.

Conclusions:

  • PRDX3 is a direct nuclear c-Myc target gene.
  • PRDX3 plays a critical role in maintaining mitochondrial function in cancer cells.
  • Targeting PRDX3 may offer a therapeutic strategy for c-Myc-driven cancers.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...